CJC-1295 (No DAC) + Ipamorelin (Research-Grade Peptide Blend)
For Laboratory Use Only – Not for Human or Veterinary Application
Product Overview
This research-only peptide blend combines CJC-1295 (No DAC) and Ipamorelin, two synthetic compounds studied for their roles in growth hormone (GH) regulation via distinct receptor pathways. Intended for in vitro and preclinical investigations, this combination supports exploration of dual-pathway GH modulation while minimizing hormonal interference observed in other analogs.
This product is not approved for human or veterinary use and is supplied solely for laboratory experimentation.
Peptide Profile
| Peptide | Mechanism |
|---|---|
| CJC-1295 (No DAC) | Synthetic GHRH analog promoting pulsatile GH release via GHRH receptor activation. The “No DAC” variant excludes the Drug Affinity Complex, offering a shorter half-life to better model natural GH rhythms. |
| Ipamorelin | Selective ghrelin receptor (GHS-R1a) agonist that stimulates GH secretion with minimal impact on cortisol, prolactin, or ACTH levels—known for its receptor specificity and reduced off-target endocrine effects. |
Synergistic Research Context
Co-administration of these peptides in experimental models allows for the study of complementary GH secretagogue pathways—simultaneously targeting GHRH and GHS-R1a receptors.
Findings in non-clinical research models have explored:
- Enhanced pulsatile GH secretion
- Controlled elevations in IGF-1 levels
- Reduced receptor desensitization compared to long-acting analogs
- Applications in protocols simulating physiological GH cycles
This peptide combination is frequently examined in research models involving:
- Skeletal muscle recovery and regeneration
- Protein synthesis and turnover dynamics
- Age-associated GH decline investigations
Applications in Laboratory Research
- Musculoskeletal Recovery Models
- Studies on tissue regeneration, collagen turnover, and muscle preservation following injury or immobilization
- Endocrine Pathway Studies
- Research into GH/IGF-1 axis feedback mechanisms and hypothalamic-pituitary signaling
- Longevity and Regenerative Investigations
- Evaluation in models related to oxidative stress, bone remodeling, and cellular aging processes
Handling & Storage
- Supplied as lyophilized powder in sterile vials
- Store at –20 °C in a dry, light-protected environment
- Reconstitute with sterile bacteriostatic water under aseptic conditions
- Use reconstituted solutions within 7–14 days when stored at 2–8 °C
- Avoid repeated freeze-thaw cycles
- Lab-grade batch testing information available upon request
Regulatory and Safety Notice
- Research Use Only: For qualified laboratory personnel exclusively
- Not FDA Approved: No medical, diagnostic, or therapeutic claims are made
- Not for Human or Veterinary Application: Do not inject, ingest, or apply to living organisms
- Professional Handling Required: To be used under institutional protocols and legal compliance guidelines
Quality Assurance
HVY Research produces all peptide blends under sterile manufacturing conditions, with routine quality and identity verification. Researchers must follow institutional laboratory safety procedures, including PPE use.
Disclaimer
This product is intended solely for research purposes. It is not approved for therapeutic, diagnostic, or clinical applications, nor for human or veterinary use. All information is provided for scientific reference only.
There are no reviews yet.